REBROVICK LINDA 4

What Happened
Linda Rebrovick, a director of HealthStream, sold 6,000 shares of HSTM stock in an open-market transaction on July 6, 2026, at $29.00 per share, generating proceeds of $174,000. This was a sale (not a purchase), which is often routine insider liquidity rather than a clear signal of company prospects.

Key Details

• Transaction date and price: 7/6/2026 — 6,000 shares sold at $29.00 each.
• Total proceeds: $174,000.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnote: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by Rebrovick on November 21, 2025.
• Filing timeliness: Report filed on 7/7/2026 for a 7/6/2026 transaction (appears timely).

Context
A 10b5-1 plan lets insiders pre-authorize trades according to a set schedule or formula; sales under such plans are commonly executed for routine portfolio management and do not by themselves indicate changed views about the company. As this is a director sale (not a purchase), investors should treat it as routine unless accompanied by other material signals or disclosures.